Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires

Brain and Behavior

Volumn 5, Issue 9, 2015, Pages

  Fischer, Anja ^a,b   Fischer, Marcus ^c   Nicholls, Robert A ^d   Lau, Stephanie ^b   Poettgen, Jana ^b   Patas, Kostas ^b   Heesen, Christoph ^b   Gold, Stefan M ^b,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Major depressive disorder; Multiple sclerosis; Self report; Sensitivity and specificity; Validation studies

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; COMORBIDITY; COMPLICATION; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REPRODUCIBILITY; SELF REPORT;

ADULT; AGED; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SENSITIVITY AND SPECIFICITY; SURVEYS AND QUESTIONNAIRES;

EID: 84941927557     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.365     Document Type: Article

References (33)

1. Ackenheil, M., G. Stotz, and R. Dietz-Bauer 1999. Mini International neuropsychiatric interview. German Version 5.0.0, DSM-IV. Psychiatrische Universitätsklinik München, München.
2. Avasarala, J. R., A. H. Cross, and K. Trinkaus 2003. Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis. Mult. Scler. 9:307-310.
3. Benedict, R. H., I. Fishman, M. M. McClellan, R. Bakshi, and B. Weinstock-Guttman 2003. Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult. Scler. 9:393-396.
4. Bjelland, I., A. A. Dahl, T. T. Haug, and D. Neckelmann 2002. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J. Psychosom. Res. 52:69-77.
5. Briken, S., S. Gold, S. Patra, E. Vettorazzi, D. Harbs, A. Tallner, et al. 2014. Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial. Mult. Scler. 20:382-390.
6. Cosco, T. D., F. Doyle, M. Ward, and H. McGee 2012. Latent structure of the Hospital Anxiety And Depression Scale: a 10-year systematic review. J. Psychosom. Res. 72:180-184.
7. DeLong, E. R., D. M. DeLong, and D. L. Clarke-Pearson 1988. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845.
8. Duivis, H. E., N. Vogelzangs, N. Kupper, P. de Jonge, and B. W. Penninx 2013. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 38:1573-1585.
9. Ensari, I., R. W. Motl, E. McAuley, S. P. Mullen, and A. Feinstein 2014. Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis. Mult. Scler. 20:602-609.
10. Feinstein, A., S. Magalhaes, J. F. Richard, B. Audet, and C. Moore 2014. The link between multiple sclerosis and depression. Nat. Rev. Neurol. 10:507-517.
11. Gold, S. M., C. Heesen, H. Schulz, U. Guder, A. Monch, J. Gbadamosi, et al. 2001. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult. Scler. 7:119-130.
12. Gold, S. M., K. C. Kern, M. F. O'Connor, M. J. Montag, A. Kim, Y. S. Yoo, et al. 2010. Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol. Psychiatry 68:553-559.
13. Gold, S. M., S. Kruger, K. J. Ziegler, T. Krieger, K. H. Schulz, C. Otte, et al. 2011. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J. Neurol. Neurosurg. Psychiatry 82:814-818.
14. Gold, S. M., M. F. O'Connor, R. Gill, K. C. Kern, Y. Shi, R. G. Henry, et al. 2014. Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling. Hum. Brain Mapp. 35:30-37.
15. Hakim, E. A., A. M. Bakheit, T. N. Bryant, M. W. Roberts, S. A. McIntosh-Michaelis, A. J. Spackman, et al. 2000. The social impact of multiple sclerosis-a study of 305 patients and their relatives. Disabil. Rehabil. 22:288-293.
16. Hautzinger, M., M. Bailer, H. Worall, and F. Keller 1995. Beck-depressions-inventar (BDI). Testhandbuch der deutschen Ausgabe. Huber, Bern.
17. Honarmand, K., and A. Feinstein 2009. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult. Scler. 15:1518-1524.
18. Ivanova, J. I., R. E. Bergman, H. G. Birnbaum, A. L. Phillips, M. Stewart, and D. M. Meletiche 2012. Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US. J. Med. Econ. 15:601-609.
19. Khan, A. Y., J. Carrithers, S. H. Preskorn, R. Lear, S. R. Wisniewski, A. John Rush, et al. 2006. Clinical and demographic factors associated with DSM-IV melancholic depression. Ann. Clin. Psychiatry, 18:91-98.
20. Lamers, F., N. Vogelzangs, K. R. Merikangas, P. de Jonge, A. T. Beekman, and B. W. Penninx 2013. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 18:692-699.
21. Minden, S. L., A. Feinstein, R. C. Kalb, D. Miller, D. C. Mohr, S. B. Patten, et al. 2014. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82:174-181.
22. Mohr, D. C., S. L. Hart, L. Julian, and E. S. Tasch 2007. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult. Scler. 13:215-219.
23. Moran, P. J., and D. C. Mohr 2005. The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. J. Behav. Med. 28:35-41.
24. Nyenhuis, D. L., S. M. Rao, J. M. Zajecka, T. Luchetta, L. Bernardin, and D. C. Garron 1995. Mood disturbance versus other symptoms of depression in multiple sclerosis. J. Int. Neuropsychol. Soc. 1:291-296.
25. Pandya, R., L. Metz, and S. B. Patten 2005. Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics 46:131-134.
26. Patten, S. B., C. A. Beck, J. V. Williams, C. Barbui, and L. M. Metz 2003. Major depression in multiple sclerosis: a population-based perspective. Neurology 61:1524-1527.
27. Patten, S. B., J. M. Burton, K. M. Fiest, S. Wiebe, A. G. Bulloch, M. Koch, et al. 2015. Validity of four screening scales for major depression in MS. Mult. Scler. pii: 1352458514559297.
28. Quaranta, D., C. Marra, M. Zinno, A. K. Patanella, M. J. Messina, C. Piccininni, et al. 2012. Presentation and validation of the multiple sclerosis depression rating scale: a test specifically devised to investigate affective disorders in multiple sclerosis patients. Clin. Neuropsychol. 26:571-587.
29. Rush, A. J., C. M. Gullion, M. R. Basco, R. B. Jarrett, and M. H. Trivedi 1996. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol. Med. 26:477-486.
30. Sa, M. J. 2008. Psychological aspects of multiple sclerosis. Clin. Neurol. Neurosurg. 110:868-877.
31. Sullivan, M. J., B. Weinshenker, S. Mikail, and S. R. Bishop 1995. Screening for major depression in the early stages of multiple sclerosis. Can. J. Neurol. Sci. 22:228-231.
32. Trivedi, M. H., A. J. Rush, H. M. Ibrahim, T. J. Carmody, M. M. Biggs, T. Suppes, et al. 2004. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol. Med. 34:73-82.
33. Wang, Y. P., and C. Gorenstein 2013. Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II. Clinics (Sao Paulo) 68:1274-1287.